Xu Zhenyu 4

What Happened
Xu Zhenyu, Chief Scientific Officer of SOPHiA GENETICS (SOPH), sold a total of 5,100 shares in two open-market transactions: 2,700 shares on 2026-04-06 at a weighted average price reported as $4.85 (proceeds $13,100) and 2,400 shares on 2026-04-07 at a weighted average price reported as $4.87 (proceeds $11,679). These were sales to satisfy tax-withholding obligations tied to recent restricted stock unit vesting and were executed under a pre-established Rule 10b5-1 trading plan (routine, non-discretionary).

Key Details

• Transaction dates and reported weighted-average prices:
  • 2026-04-06 — 2,700 shares sold, $4.85 (reported), proceeds $13,100. (See footnote F2: actual prices ranged $4.67–$4.95.)
  • 2026-04-07 — 2,400 shares sold, $4.87 (reported), proceeds $11,679. (See footnote F3: actual prices ranged $4.69–$4.98.)
• Total shares sold: 5,100; total proceeds reported: $24,779.
• Purpose: Sales were made to satisfy tax withholding on RSU vesting (vest dates April 2 and 3, 2026) and were effected under a pre-established Rule 10b5-1 plan (footnote F1).
• Shares owned after the transactions: Not specified in the provided filing excerpt.
• Filing: Form 4 filed with the SEC on 2026-04-08; no late-filing indication shown in the provided information.

Context
These transactions were tax-withholding sales under a 10b5-1 plan, which are generally considered routine and do not necessarily indicate a change in insider sentiment. The filing reports weighted-average prices and includes footnotes offering to provide per-trade price breakdowns on request.